This highly powered clinical trial compared the effect of prophylactic platelet transfusion at three platelet doses on grade 2 or greater bleeding in 1,272 thrombocytopenic recipients affected by hematologic conditions. The study showed no effect on bleeding incidence at doses between 1.1 and 4.4 x 10e11 per recipient body surface square meter.

– Paolo Rebulla